Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Crossbow Therapeutics

Clinical trials sponsored by Crossbow Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for Hard-to-Treat blood cancers? early trial of CBX-250 begins Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Can a new drug take on multiple tough cancers?

Disease control Not yet recruiting

This early-stage trial tests an investigational drug called CBX-663 in adults with certain advanced cancers that have not responded to standard treatment or have returned. The study includes people with blood cancers (like AML, MDS, or CMML), advanced solid tumors, or a type of b…

Phase 1 • Sponsor: Crossbow Therapeutics, Inc. • Aim: Disease control

Last updated Aug 23, 2026 00:00 UTC